AHA GUIDELINES Bundle (free trial)

AHA/ASA Early Management of Acute Ischemic Stroke 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1542862

Contents of this Issue

Navigation

Page 37 of 57

38 General Supportive Early Management 4.7.4. Endovascular Techniques COR LOE Recommendations rombectomy General Techniques 1 A 1. In patients with AIS due to an LVO, EVT with stent retrievers, contact aspiration, or combination techniques is recommended to achieve rapid and adequate reperfusion. 1 A 2. In patients with AIS undergoing EVT, reperfusion to an extended TICI grade 2b/2c/3 is recommended as early as possible within the therapeutic window to achieve maximum functional benefit at 90 days. 1 B-R 3. In patients with AIS undergoing EVT, either general anesthesia or procedural sedation are recommended to facilitate EVT. 2b B-R 4. In patients with AIS undergoing EVT, the use of a proximal balloon to guide catheters to achieve improved outcomes remains uncertain. 3: No benefit A 5. In patients with AIS from occlusion of medium or distal vessels of the anterior, middle (nondominant or codominant M2, M3), or posterior cerebral arteries, EVT with stent retrievers is of no benefit for improving functional outcomes. rombectomy Adjunctive Techniques 2b B-NR 6. In patients with AIS undergoing EVT in the setting of tandem extracranial-intracranial anterior circulation occlusions, acute treatment of both, including emergent extracranial stenting, may be reasonable to achieve higher good functional outcome. 2b B-NR 7. In patients with AIS in the setting of failed EVT, the use of rescue intracranial balloon angioplasty and/or stenting to improve functional outcome remains uncertain. 2b B-R 8. In patients with AIS who achieve complete or near-complete EVT (modified TICI 2b or greater), the administration of adjunctive intraarterial thrombolytics with urokinase, alteplase, or tenecteplase may be reasonable to improve cerebral reperfusion and 90-day functional outcome. 3: No benefit B-R 9. (New and of High Impact) In the management of patients with AIS in the setting of LVO, preoperative administration of tirofiban before EVT is not useful to improve 90-day functional outcome.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - AHA/ASA Early Management of Acute Ischemic Stroke 2026